134 related articles for article (PubMed ID: 31763315)
1. Randomised Comparison of Safety Profile and Short Term Response of Itraconazole, Voriconazole and Amphotericin B in the Management of Chronic Invasive Fungal Rhinosinusitis.
Debbarma S; Gupta R; Patro SK; Gupta AK; Pandhi P; Shafiq N
Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 3):2165-2175. PubMed ID: 31763315
[TBL] [Abstract][Full Text] [Related]
2. Role of preoperative versus postoperative itraconazole in allergic fungal rhinosinusitis.
Verma RK; Patro SK; Francis AA; Panda NK; Chakrabarti A; Singh P
Med Mycol; 2017 Aug; 55(6):614-623. PubMed ID: 27838640
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy of amphotericin B and itraconazole in chronic invasive fungal sinusitis.
Mehta R; Panda NK; Mohindra S; Chakrabarti A; Singh P
Indian J Otolaryngol Head Neck Surg; 2013 Aug; 65(Suppl 2):288-94. PubMed ID: 24427663
[TBL] [Abstract][Full Text] [Related]
4. Chronic invasive fungal sinusitis: characterization and shift in management of a rare disease.
D'Anza B; Stokken J; Greene JS; Kennedy T; Woodard TD; Sindwani R
Int Forum Allergy Rhinol; 2016 Dec; 6(12):1294-1300. PubMed ID: 27463614
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands.
Jansen JP; Meis JF; Blijlevens NM; van't Wout JW
Curr Med Res Opin; 2005 Oct; 21(10):1535-46. PubMed ID: 16238893
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of preoperative itraconazole in allergic fungal rhinosinusitis.
Patro SK; Verma RK; Panda NK; Chakrabarti A; Singh P
Am J Rhinol Allergy; 2015; 29(4):299-304. PubMed ID: 26163250
[TBL] [Abstract][Full Text] [Related]
8. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy.
Gerlinger I; Fittler A; Fónai F; Patzkó A; Mayer A; Botz L
Eur Arch Otorhinolaryngol; 2009 Jun; 266(6):847-55. PubMed ID: 18953552
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough mucormycosis after voriconazole use in a case of invasive fungal rhinosinusitis due to Curvularia lunata.
Gupta N; Kumar A; Singh G; Ratnakar G; Vinod KS; Wig N
Drug Discov Ther; 2017; 11(6):349-352. PubMed ID: 29332895
[TBL] [Abstract][Full Text] [Related]
10. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
11. Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
Manavathu EK; Abraham OC; Chandrasekar PH
Clin Microbiol Infect; 2001 Mar; 7(3):130-7. PubMed ID: 11318811
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo.
Zhang J; Wu X; Li M; Huang J; Yin S; Huang H; Lu C; Xi L
Rev Inst Med Trop Sao Paulo; 2019 Jun; 61():e31. PubMed ID: 31241660
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis. Can recidive polyposis be prevented?].
Gerlinger I; Fittler A; Mayer A; Patzkó A; Fónay F; Pytel J; Botz L
Orv Hetil; 2008 Sep; 149(37):1737-46. PubMed ID: 18805757
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
García-Martos P; García-Agudo L; Gutiérrez-Calzada J; Ruiz-Aragón J; Saldarreaga A; Marín P
Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):15-8. PubMed ID: 15701327
[TBL] [Abstract][Full Text] [Related]
16. Chronic Invasive Fungal Rhinosinusitis in Immunocompetent Patients: A Retrospective Chart Review.
Alotaibi NH; Omar OA; Altahan M; Alsheikh H; Al Mana F; Mahasin Z; Othman E
Front Surg; 2020; 7():608342. PubMed ID: 33392248
[No Abstract] [Full Text] [Related]
17. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
[TBL] [Abstract][Full Text] [Related]
18. Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
McGinnis MR; Nordoff N; Li RK; Pasarell L; Warnock DW
Med Mycol; 2001 Aug; 39(4):369-71. PubMed ID: 11556767
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
Oakley KL; Moore CB; Denning DW
J Antimicrob Chemother; 1998 Jul; 42(1):91-4. PubMed ID: 9700534
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Swinne D; Watelle M; Nolard N
Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
